跳至主要内容
临床试验/CTRI/2020/10/028282
CTRI/2020/10/028282招募中3 期

Management of polycystic ovarian syndrome with homoeopathic intervention versus standard conventional treatment -A non-randomised comparative study

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Female aged 18 to 36 years
  • 2.Oligomenorrhea/amenorrhea (two years after menarche)
  • 3.Ultrasound findings of Polycystic ovaries
  • 4.Clinical evidence of acne (acne global severity scale score 1 and above)
  • 5.Written Informed consent from the patient

排除标准

  • 1. History of DM, Cushing disease, hyperprolactinemia, untreated hypo or hyperthyroidism, adrenal hyperplasia and adrenal tumor
  • 2. Ovarian tumor, hyperthecosis and significant renal impairment
  • 3. History of intake of drugs aldactone or metformin or history of OCP use or intake of drugs known to interfere with carbohydrate metabolism prior 4 weeks before enrolment.
  • 4. Pregnancy, breast feeding
  • 5. Cases with other systemic diseases or infections or on other treatment therapies

研究者

发起方
Central Council for Research in Homoeopathy

相似试验